Urologic Oncology (Cancer)
Urologic Oncology is a subspecialty of Urology. Cancer can develop in any organ of the urinary system and the male reproductive system. As with other forms of cancer, the earlier a urological cancer is detected, the greater the chance of successful treatment, that is, removing it before it becomes aggressive and spreads.
Not all abnormal masses of cells are cancerous. A biopsy -by removing a small sample of tissue so the cells can be examined with a microscope will determine if a tumor is cancerous (malignant) or non-cancerous (benign).
It’s important to know the symptoms of urological cancer and see your doctor as soon as possible if you have any of them. Of course, most symptoms have several possible causes. Only a medical examination can determine if the actual cause is cancer or another condition. Seeing your doctor can ease your fears.
The Michigan Institute of Urology are committed to providing outstanding care by offering the latest and most effective therapies in a compassionate setting.
Patient Information for Urologic Oncology
Thousands of men and women are diagnosed each year with cancer of the bladder, kidney and the prostate. New breakthroughs in cancer care, treatment options and ongoing reasearch for potential cures of urologic malignancies give new hope for patients from all walks of life.
We have provided you with a wealth of information on Urologic Oncology conditions, treatments and technology below. To learn more about your office visit, what to expect and what to bring to your appointment please click here.
| Associated Treatments |
| Observation / Active Surveillance |
Radical Prostatectomy |
| Laparoscopic Robotic Prostatectomy |
Radical Perineal Prostatectomy |
| Radical Retropubic Prostatectomy |
Targeted Cryotherapy of the Prostate |
| Radiation Therapy |
Radiation Therapy-Brachytherapy High Dose Rate / Low Dose Rate |
| Radiation Therapy-Intensity Modulated Radiation Therapy (IMRT) |
Endoscopic Resection of the Bladder Tumor |
| Intravesical Chemotherapy (BCG, Mitomicin C ) |
Organ Preservation - Combination Chemotherapy and Radiation Therapy |
| Partial Cystectomy (Robotic,Laparoscopic, or Open) |
Radical Cystectomy (Robotic,Laparoscopic, or Open) |
| Urinary Diversions ( Ileal Conduit or Neobladder ) |
Radical Nephrectomy (Robotic,Laparoscopic, or Open) |
| Partial Nephrectomy (Robotic,Laparoscopic, or Open) |
Nephroureterectomy (Robotic,Laparoscopic, or Open) |
| Cryotherapy (Robotic, Laparoscopic, or Open) |
Radiofrequency Ablation (Robotic,Laparoscopic, or Open) |
| Distal Ureterectomy (Robotic,Laparoscopic, or Open) |
Laser Ablation of Ureteral Tumor |
| Adrenalectomy (Robotic, Laparoscopic, or Open) |
Radical Orchiectomy |
| Retroperitoneal Lymph Node Dissection |
Systemic Chemotherapy |
| Partial Penectomy |
Total Penectomy |
| MOHS Surgery |
Laser Therapy |
| Chemotherapy |
Prostate Cancer Screening and Prevention |
| Valstar - (Valrubicin) |
|
|
